317 related articles for article (PubMed ID: 17682213)
1. [Bisphosphonate treatment against breast cancer with bone metastases].
Kohno N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
[No Abstract] [Full Text] [Related]
2. [Clinical study of bisphosphonates for bone metastasis in breast cancer].
Yamada K; Kohno N
Nihon Rinsho; 2007 Nov; 65 Suppl 9():352-5. PubMed ID: 18161130
[No Abstract] [Full Text] [Related]
3. Bisphosphonates--role in cancer therapies.
Mehrotra B
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
[No Abstract] [Full Text] [Related]
4. [Clinical implications of bisphosphonate for bone metastases of prostate cancer].
Kitagawa Y; Konaka H; Mizokami A; Namiki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():356-9. PubMed ID: 18161131
[No Abstract] [Full Text] [Related]
5. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero SL; Fantasia J; Carlson E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
[No Abstract] [Full Text] [Related]
6. Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.
Ding X; Fan Y; Ma F; Li Q; Wang J; Zhang P; Yuan P; Xu B
Breast; 2012 Aug; 21(4):544-9. PubMed ID: 22627092
[TBL] [Abstract][Full Text] [Related]
7. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
Delibasi T; Altundag K; Kanlioglu Y
J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
[No Abstract] [Full Text] [Related]
8. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy.
Mignogna MD; Fedele S; Lo Russo L; Ciccarelli R; Lo Muzio L
J Clin Oncol; 2006 Mar; 24(9):1475-7. PubMed ID: 16549843
[No Abstract] [Full Text] [Related]
9. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
Van Poznak C
Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate osteonecrosis of the jaws in cancer patients.
Kyrgidis A; Andreadis C
Breast; 2009 Oct; 18(5):335. PubMed ID: 19783147
[No Abstract] [Full Text] [Related]
11. Pharmacotherapy of bone metastases in breast cancer patients.
Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonate induced osteonecrosis of the jaw masquerading as tumor: a word of caution for oral surgeons and oncologists.
Chaturvedi P; Pai PS; Chaukar DA; Gupta S; D'cruz AK
Eur J Surg Oncol; 2010 Jun; 36(6):541-5. PubMed ID: 20071132
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw in randomized clinical trials.
Kyrgidis A
Breast Cancer Res Treat; 2010 Jan; 119(1):253-4. PubMed ID: 19585235
[No Abstract] [Full Text] [Related]
14. Sowing the soil for cure? Results of the ABCSG-12 trial open a new chapter in the evolving adjuvant bisphosphonate story in early breast cancer.
Bedard PL; Body JJ; Piccart-Gebhart MJ
J Clin Oncol; 2009 Sep; 27(25):4043-6. PubMed ID: 19652062
[No Abstract] [Full Text] [Related]
15. Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer.
Crawford BS; McNulty RM; Kraut EH; Turowski RC
Cancer Invest; 2009 Dec; 27(10):984-8. PubMed ID: 19909013
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
Costa L
Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
18. Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients.
Kyrgidis A; Triaridis S; Vahtsevanos K; Antoniades K
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1125-34. PubMed ID: 19671032
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
Tsai WS; Haghighi K; Placa SJ
Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: recommendations for prevention and treatment.
Fehm T; Felsenberg D; Krimmel M; Solomayer E; Wallwiener D; Hadjii P
Breast; 2009 Aug; 18(4):213-7. PubMed ID: 19651512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
